维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="BLIND E"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pancreatic safety of incretin- based drugs--FDA and EMA assessment显示文摘	Egan AG Blind E Dunder K		N Engl J Med0，370，9：	1
2	The influence of strategic patenting on companies'patent portfolios显示文摘	Blind K Cremers K Müller E	2009	Research Policy2009，38，2：	1
3	Pancreatic safety of incretin-based drugsd FDA and EMA assessment显示文摘	Egan AG Blind E Dunder K	2014	N Engl J Med2014，370，9：	1
4	Pancreatic safety of incretin - based drugs--FDA and EMA assessment 显示文摘	Egan A G Blind E Dunder K	2014	New England Journal of Medicine2014，370，9：	1
5	The influence of strategic patenting on companies' patent portfolios 显示文摘	BLIND K CREMERS K MUELLER E	2009	Research Policy2009，38，2：	1
6	Pancreatic safety ofincretin-based drugs-FDA and EM A assessmenl 显示文摘	EGAN AG BLIND E DUNDER K	2014	N Engl JMed2014，370，9：	1
7	Pancreatic safety of incretin-based drugs--FDA and EMA assessment显示文摘	Egan AG Blind E Dunder K	2014	N Engl J Med2014，370，9：	1
8	The Influence of Strategic Patenting on Companies' Patent Portfolios显示文摘	Blind K Cremers K Müller E		0，，02：	1
9	The Influence of Strate- gic Patenting on Companies' Patent Portfolios 显示文摘	Blind K Cremers K Mueller E	2009	Research Policy2009，38，2：	1
10	The influence of strategic pa-tenting on companies’ patent portfolios 显示文摘	Blind K Cremers K Muller E	2009	Research Policy2009，38，2：	1
11	Emerging ways to ad dress the reemerging conflict between patenting and techno- logical standardization 显示文摘	RUDI B IVERSEN E BLIND K	2011	Industrial and Corporate Change2011，21，4：	1
12	Pancreatic safety of incretin-based drugs-- FDA and EMA assessment显示文摘	Egan AG Blind E Dunder K	2014	N Engl J Med2014，370，9：	1
13	The influence of strategic patenting on companies' patent portfolios 显示文摘	Blind K Cremers K Mueller E	2009	Research Policy2009，38，：	1
14	The Influence of Strategic Pa- tenting on Companies' Patent Portfolios 显示文摘	Blind K Cremers K Mueller E	2009	Research Policy2009，38，：	1
15	The influence of st- rategic patenting on companies' patent portfolios显示文摘	Blind K Cremers K Mueller E L	2009	Re- search Policy2009，38，2：	1
16	Enhancing the Physical and Social Self through Recreational Activity: Accounts of Indi-viduals with Physical Disabilities 显示文摘	Blinde E M McClung L R	1997	Adapted Physical Ac- tivity Quarterly1997，14，4：	1
17	The influence of strategic patenting on companies'patent portfolios显示文摘	BLIND K CREMERS K MUELLER E		0，，38：	1
18	Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay显示文摘	Schmidt Gayk H Armbruster FP	1987	Clin Chem1987，33，8：	1
19	Twenty years of progress with parathyroid hormone (PTH): from specialized and ' difficult' measurement to common laboratory parameter and treatment option in osteo- porosis显示文摘	Blind E	2008	Clinical Laboratory2008，54，1112：	1
20	The influence of strategic patenting on companies' patent portfolios显示文摘	BLIND K CREMERS K MUELLER E	2009	Research Policy2009，38，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示